HoloSurge Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers
- Coordinator
- Holocare AS, Norway
- Runs
- 1 January 2024 to 31 December 2027
- Status
- Running
- EU funding
- €6.8m
- Total cost
- €7.7m
- Partners
- 15 organisations in 10 countries
- Type
- Innovation Action
- Grant agreement
- 101137233
What the project is doing
In the project's own words, from its summary on CORDIS.
Perioperative care is an intricate process that encompasses 1) preoperative evaluation, surgical planning and preparation; 2) intraoperative procedure; and 3) postoperative management. Perioperative care depends on clinical decision-making, a continuous process that involves many healthcare professionals (incl. radiologists, surgeons, anaesthesiologists, nurses, and others) who – based on the best available evidence, clinical experience, and the patient's individual circumstances – make informed decisions on the best course of action.
Even though advancements in medical imaging modalities (CT, MRI, ultrasound) have greatly improved surgical outcomes, their interpretation towards deciding a specific course of action remains subjective. In addition, these modalities have several limitations when used alone (e.g., missed lesions; cannot provide a 3D visualization of key structures such as vessels), ultimately failing to provide a full picture of the patient’s anatomy that is shared and unambiguously understood by all in the assigned team.
Due to these limitations, there are often suboptimal decisions that add to a cumulative risk of surgical complications in perioperative care. HoloSurge is a joint undertaking that brings European scientists and clinicians from high-tech companies, clinical centres, and research institutions in a consortium to deploy an innovative AI-based medical system that: i) enables automatic fusion and segmentation of state-of-the-art imaging modalities for interactive 3D holographic visualization of patients’ organs; ii) provides real-time surgical navigation; and iii) allows real-time cell-level cancer diagnostics.
The solution will provide surgical teams with an unmatched holistic view of the patient’s anatomy and pathology in real-time at point of care, before and during surgery. This innovation will be validated for cancer interventions, while creating a trail of better-informed perioperative decision-making that can save countless lives.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Holocare AS | Oslo | Norway | Coordinator |
| United European Gastroenterology GmbH | Vienna | Austria | Participant |
| Digestive Cancers Europe Dice | Bruxelles / Brussel | Belgium | Participant |
| Cyens Centre of Excellence | Nicosia | Cyprus | Participant |
| Klinikum Der Ludwig-Maximilians-Universitat Munchen | Munchen | Germany | Third party |
| Ludwig-Maximilians-Universitaet Muenchen | Planegg | Germany | Participant |
| Metropolia Ammattikorkeakoulu Oy | Helsinki | Finland | Participant |
| Semmelweis Egyetem | Budapest | Hungary | Associatedpartner |
| Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis | Amsterdam | Netherlands | Participant |
| Oslo Universitetssykehus Hf | Oslo | Norway | Participant |
| Sintef AS | Trondheim | Norway | Participant |
| Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie -Panstwowy Instytut Badawczy | Warszawa | Poland | Participant |
| Orbit21 Consulting Ltd | Steyning | United Kingdom | Associatedpartner |
| The Leeds Teaching Hospitals National Health Service Trust | Leeds | United Kingdom | Associatedpartner |
| University of Leeds | Leeds | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI